Deutsch | English | Español | Français | Italiano | Português | Русский | العربية | 日本語 | 简体中文 | 繁體中文 | 한국의 | Türk | Polski
LOGO
全球生物醫藥及醫藥行業B2B門戶網站
產品/服務 供應商 目錄和文獻    
搜尋
or
home Product News Catalogs Web TV News & Topics Featured Articles Trade Shows Sourcing Help My allbiomedical
產品新聞內容
allbiomedical > 產品新聞內容 > AB Sciex launched Eksigent nanoLC
  
Share |
AB Sciex launched Eksigent nanoLC

Eksigent nanoLC, AB Sciex

AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the Eksigent ekspertTM nanoLC 400 system. The new Eksigent system is the world's first plug-and-play liquid chromatography system that integrates nano LC and micro LC on the same platform, providing the broadest functionality with the benefits of both flow rate ranges. This flexibility enables fast and easy switching between high-sensitivity discovery proteomics and high-throughput targeted peptide quantitation commonly used in advanced biological studies. The ekspert nanoLC 400 system is on display at the HUPO conference in Boston this week.

Discovery proteomics is a strategy in which an LC system in combination with a mass spectrometer is used to identify and quantify proteins in a global untargeted manner. Once a set of interesting proteins has been identified, targeted techniques are used to verify and validate the results in further sample types by targeted peptide quantitation.

The ultimate goal is to advance the understanding of systems biology by identifying new biomarkers or new proteins of interest and to potentially improve medical methodologies. The new Eksigent ekspert nanoLC 400 system improves the efficiency of these proteomics workflows by providing the highest separation quality and reliability.

The novel, interchangeable LC flow modules in the nanoLC 400 system allow scientists to quickly go from low flow nano LC to a higher flow rate of micro LC, with a simple switch of a module. This is ideal for mixing non-targeted and targeted approaches, especially when used with a next-generation mass spectrometer like the AB SCIEX TripleTOF® 5600+ system. In addition, the retention time stability afforded by advances in microfluidic flow control (MFCPlusTM technology) is critical for quantitative applications such as Scheduled MRMHR Workflow and SWATHTM Acquisition.

"Scientists want to do more with less," said Remco van Soest, Product Manager for the ekspert nanoLC 400 system at AB SCIEX. "Because the new ekspert nanoLC 400 system bridges the gap between low flow and higher flow rates in LC/MS workflows, laboratories no longer need separate LC systems to go from discovery to verification and validation in the protein biomarker research continuum. The plug-and-play functionality of the nanoLC system opens up new possibilities for biomedical and proteomics researchers."

The nanoLC 400 system is the only low-flow system that - when combined with the existing Eksigent cHiPLC® system - enables highly reproducible proteomics across a broad range of workflows in busy multi-user, multi-instrument laboratories. The cHiPLC system is a chip-based platform that serves as a "docking station" for easy switching between different types of experiments, such as direct injection and trap-loading. With the new nanoLC 400 system, injections can now be done 5x to 10x faster with a higher precision autosampler for nano LC.

"The Eksigent nanoLC system enables me to go to a higher flow rate within the same system, when I need it, and that is a tremendous benefit," said Nick Morrice, Group Leader at the Beatston Institute for Cancer Research in Glasgow, Scotland. "Nano LC with 75 um ID columns is great for thorough, detailed discovery, but it takes longer than I would like. Using microflow LC on my TripleTOF 5600 system with the 25 um ID hybrid electrode and the DuoSpray Source, my routine protein identifications using the same injection volume are three times faster than nano LC. The flexibility of being able to switch between nano LC and micro LC in minutes is really valuable. It's a step forward for the proteomics community."

Quantitative proteomics research continues to evolve, with a continued shift toward targeted analysis and more recently data-independent analysis. This shift requires a new level of reproducibility and integration for qualitative and quantitative analysis. The Eksigent ekspert nanoLC 400 system is designed for next-generation proteomics and data-independent workflows, such as MS/MSALL with SWATHTM Acquisition. Released earlier this year, SWATH Acquisition is a groundbreaking mass spectrometry-based technique that enables quantification of all detectable peptides and proteins in a sample from a single analysis.

標籤:
 
關於本公司:
AB SCIEX is a global leader in the development of best-in-class technologies that help answer complex scientific challenges and improve our world. We create scientific instrumentation, software and services for the life science, clinical research and industrial markets, empowering our customers with technologies that are used in drug discovery and manufacturing, food and environmental safety, and clinical research. With a more than 20-year history of innovation and market leadership under the Applied Biosystems/MDS Analytical Technologies joint venture, we now operate as AB SCIEX, a new company within the Danaher Corporation.  
公司信息:
公司名稱: AB Sciex Pte. Ltd.
地址: 500 Old Connecticut Path
城市: Framingham
省/州: MA
ZIP: 01701
國家: U.S.A.
電話號碼: +1-508-383-7961
傳真: + - -
 
備註:本內容所提到的品牌,產品名稱,產品編號,其版權都屬於該公司所有。
 
這個公司的產品新聞

2010-08-03

High-Resolution Mass Spectrometer
相關產品新聞
專題網頁
內容
· Home
· 產品新聞
· 線上型錄
· 網路TV
· 產業新聞
· 技術文件
· 國際展會
· 採購協助
· My Allbiomedical
別冊附錄
· 供應商名錄
· 國際展會專刊
· 專案活動
Allbiomedical.com
· 關於我們
· 推廣您的業務
· 刊登廣告
· 徵求合作夥伴
· 新聞發佈
· 聯繫我們
· 使用條款
· 隱私權政策
· 入門方案
· 網站地圖
B2B產業入口網站聯盟
· Allitwares.com
· Allmetalworking.com
· Allbiomedical.com
· Allautowares.com
Buy Engineer Sample Kits
OEM Sourcing
語言
· Deutsch
· English
· Español
· Français
· Italiano
· Português
· Русский
· العربية
· 日本語
· 简体中文
· 繁體中文
· 한국의
· Türk
· Polski
 
   

版權2012年Allitwares公司版權所有。 www.allbiomedical.com是Allitwares公司的產業入口網站之一
www.allbiomedical.com是B2B線上網路市集|B2B產業入口網路平台|生醫、醫療、製藥業的B2B外銷推廣平台